PerkinElmer
check quantity

CellCarrier-384 Black, Optically Clear Bottom, Tissue Culture Treated, Sterile, 384-Well with Lid, Case of 40

384-well tissue culture-treated (TC-treated) polystyrene microplate with black walls and clear bottom for cell-based assays, high content analysis, and microscopic viewing.

Part Number
Unit Size
List Price
Your Price
Quantity
6007550
Case of 40
1144.00 USD
 
more
6007558
Case of 160
4289.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

Well Plate Dimensions

Well format: 384-well
Description Specification
Number of Rows 16
Number of Columns 24
Well volume 105 µL
Recommended working volume 25 µL- 90 µL
Height (mm) 14.4
Length (mm) 127.76
Width (mm) 85.48
Well diameter (mm) 3.70-3.26
Well depth (mm) 13.95
A1 to top offset (mm) 8.99
A1 to side offset (mm) 12.13
Well-to-well spacing (mm) 4.5

Specifications

Automation Compatible Yes
Coating Treatment TC-treated, Sterile
Color Black/Clear Bottom
Detection Method Confocal Imaging, Fluorescence, High Content Imaging
Material Polystyrene
Product Brand Name CellCarrier
Shipping Condition Ambient
Sterile Yes
Unit Size Case of 40
Wells Number 384 well plate
Resources, Events & More
  • All

Brochure

Drug Discovery Screening Solutions Brochure

Find out about our range of integrated solutions for drug discovery screening in this e-brochure.

Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automated liquid handling, assays and reagents, imaging and detection systems, and informatics.

Working independently or together, with our solutions you can achieve consistent and accurate results. By accelerating the identification and characterization of effective and safe drug candidates, the PerkinElmer portfolio enables you to optimize efficiency in your lab and deliver more actionable, real-world results.

Download the brochure to learn more about how we can partner with you so that you can discover smarter, more effective, data-driven breakthroughs in the critical screening stages of drug discovery and development.

PDF 4 MB